🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Start-up @Siloton has snagged about $1 million to fund a chip that creates OCT images of patient's eyes for treating age-related macular degeneration. Nice to see funding for OCT research, which could ultimately drive adoption & reduce costs. tinyurl.com/2hrf3av9 #medtech

“It’s not that AI will replace the physician,” said Carolyn Meltzer, MD, dean of the Keck Medicine of USC . “It’s that the physician who uses AI will replace the physician who does not use AI.” $PINK.V $PYNKF keck.usc.edu/news/the-futur…

We're excited be headed to the San Antonio Breast Cancer Symposium Dec. 10-13! Stop by Booth 1417 to say hi and get a demo of the Perimeter S-Series OCT device, our pioneering medical imaging system that can deliver ultra-high-res margin visualization of excised tissue in the OR.

AI can help bring higher quality care to more patients. This is what we aim to do Perimeter Medical Imaging AI $PINK.V $PYNKF theglobeandmail.com/business/artic…

I wonder who Chamath Palihapitiya and Tucker Carlson are talking about at the 1:07:00 mark. 🤔

Seems like a good time to remind everyone that even though Perimeter Medical Imaging AI is a Canadian listed company, we both manufacture and sell 100% of our current and next generation products within the United States. $PINK.V $PYNKF nbcnews.com/news/amp/rcna1…

Nice to see Alastair Thompson of @BCMHouston recognized for his groundbreaking work in #breastcancer! Dr. Thompson participated in the clinical trial of our investigational tech w/ #AI for visualizing tissue using OCT during breast cancer surgery. bit.ly/4aUn6Bk

It’s opening night at #ASBrS25! Stop by Booth 422 tomorrow to see how Perimeter’s S-Series OCT provides microscopic margin visualization and cellular-level imaging power at 2mm depth. And meet with our Med Affairs team to get an investigational #AI demo! bit.ly/42EAQ0x

#ICYMI at #LSIUSA25, Perimeter CEO Adrian Mendes explains the powerful combination of #AI + advanced #medtech — working together to reduce surgery times and lower barriers to adoption to benefit more surgeons and patients. Full video at bit.ly/4jbufQX. $PINK.V $PYNKF

Perimeter will report its first quarter 2025 financial results after market close tomorrow, Tuesday, May 13, followed by a conference call at 5 p.m. ET to discuss the results and provide a corporate update. bit.ly/42RukDI $PINK.V $PYNKF #medtech

Nice description of our technology by our co-founder Andrew Berkeley here in this Radiology Today article.

Our technology team is world class and they create a competitive moat for us to solve some very high impact healthcare problems. Thanks for the recognition #TAGAwards! $PINK.V $PYNKF

It was fun to talk to Sanjay Juneja, MD because we were able to get into both the tech and the clinical impact of the tech on patients. Which is all that really matters. Go Perimeter Medical Imaging AI! $PINK.V $PYNKF

When surgeons get “clean margins” it means they got a clean border of healthy tissue around the cancer they’ve removed. For some cancers, re-operation rates are as high as 1-4 or 1-5 because a surgeon didn’t get clean margins. At Perimeter, we aim to change that! $PINK $PYNKF

Special shout-out to Jennifer Tittensor, a general surgeon for Timpanogos Regional Hospital, for being the first to contribute to our newly launched OCT-Tissue Surveillance Registry. ir.perimetermed.com/news-events/pr… #medtech

Reoperation rates after breast-conserving surgery remain high—impacting patients, healthcare systems, and costs. This white paper explores the scope of the issue and why new strategies are needed. 📖 Read more: bit.ly/3VuGv6b #medtech #breastcancer

📢 CEO Adrian V. Mendes of Perimeter Medical Imaging AI (TSX‑V: $PINK | OTCQX: PYNKF) presents at the Life Sciences Virtual Investor Forum on June 12 at 12:30 PM ET. Hear the latest on our OCT tech as we work to redefine surgical oncology. newswire.ca/en/releases/ar… #MedTech #InvestorRelations

“We didn’t get all the cancer”—one of the hardest parts of breast surgery. OCT can help change that. – Dr. Sommer Gunia The S-Series is indicated for general tissue imaging and has not been evaluated by FDA for specific use. perimetermed.com/disclosures 📰 bit.ly/4jLTLMa

Equity in healthcare starts with access. On TAG’D: Beyond the Award podcast, I spoke with Justin Starbird about how Perimeter Medical Imaging AI’s AI-powered imaging aims to close the gap in cancer care—starting in the OR. Proud of our journey. 🎧 tagawards.co/podcast/celebr… $PINK.V $PYNKF

🎥Mary Leas reflects on her breast cancer journey—and why care, clarity, and support matter. At Perimeter Medical Imaging AI, we’re committed to advancing technologies to help healthcare providers make informed decisions—because every patient deserves that clarity. #medtech #patientcare